---

$6.63

+0.0200 ( +0.30% ) 0.0K

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-09	Sale	-24648.00	Yamagishi-Dressler Tomoko
2024-02-09	Sale	-35211.00	Beaver Sandra
2024-02-09	Sale	-35211.00	Avelar Rui
2024-02-09	Sale	-134976.00	MOATAZEDI DAVID
2024-02-02	Sale	-11931.00	Parschauer Karah Herdman
2023-12-08	Sale	-51348.00	MOATAZEDI DAVID